AVTX 股东权益历史(2016–2025)
Avalo Therapeutics, Inc. (AVTX) 各财年年末股东权益(来自 SEC 财报)。
$83.0MFY2025 · FY2016 以来:$207,002 → $83.0M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | $83.0M | -37.6% |
| FY2024 | $133.0M | +1721.4% |
| FY2023 | $7.3M | +166.9% |
| FY2022 | -$10.9M | -147.3% |
| FY2021 | $23.1M | -6.0% |
| FY2020 | $24.6M | +17.0% |
| FY2019 | $21.0M | +0.4% |
| FY2018 | $20.9M | -25.0% |
| FY2017 | $27.9M | +13358.6% |
| FY2016 | $207,002 | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议